Levonorgestrel-releasing implants are long acting contraceptives, approved for 5 years of
continuous use. Two marketed systems, the six capsule Norplant® 1 and the two rod …

Progestogen-only contraceptive implants are highly effective. In most studies, 5-year
cumulative pregnancy rates are less than 1.5/100 women for Norplant and Norplant II. No …

BACKGROUND Long-acting reversible contraceptive (LARC) methods are highly effective in
preventing unintended pregnancies. However, their uptake is low in much of the developed …

Modern contraceptive methods represent more than a technical advance: they are the
instrument of a true social revolution—the “first reproductive revolution” in the history of …

Today, a new category of fertility-regulating agents has been created: long-acting, reversible
hormonal contraceptives; they minimize compliance, while maximize effectiveness. They …

Objective To assess the relative contraceptive effectiveness, tolerability and acceptability of
the levonorgestrel‐releasing (20 μg per day) intrauterine system (LNG‐20) compared with …

Progestogen-only implantable contraceptives are used by increasing numbers of women
worldwide. This review outlines the evidence accumulated on these methods to date …

Unintended pregnancies constitute a global problem associated with substantial costs to
health and social services, and emotional distress to women, their families and society as a …

BACKGROUND: Within the setting of a UK community sexual health service, the cost-
effectiveness of Implanon® and oral contraception provision over a 36-month period was …

Intrauterine contraception is used by about 100 million women worldwide, making it the most
popular form of fertility regulation. In UK community contraception clinics, however, long …